Share on StockTwits

KBC Securities hoisted their target price on shares of Prosensa Holding (NYSE:RNA) to $11.00 in a research note issued on Wednesday. The firm currently has an “accumulate” rating on the stock. KBC Securities’ price target would indicate a potential upside of 10.22% from the stock’s previous close.

Prosensa Holding (NYSE:RNA) opened at 9.98 on Wednesday. Prosensa Holding has a 1-year low of $3.43 and a 1-year high of $34.55. The stock has a 50-day moving average of $7.01 and a 200-day moving average of $5.97. The company’s market cap is $359.0 million.

Prosensa Holding (NYSE:RNA) last released its earnings data on Tuesday, May 20th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.25.

Prosensa Holding N.V., formerly Prosensa Holding B.V., is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating (NYSE:RNA)-modulating, therapeutics for the treatment of genetic disorders.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.